Xspray Pharma: Q2 characterized by preparations
Research Note
2018-08-24
11:30
Xspray's second quarter has been filled with preparatory work, and important study data for HyNap-Dasa is expected by the end of Q3.
MS
Mathias Spinnars
Disclosures and disclaimers